Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers.

When analyzing the drug delivery product pipeline, three key technologies stand out. Check out the latest market research.

While DNA microarrays are already widely used, adapting the technology to RNA microarrays has proved difficult due to the lower stability of RNA. In 2018, the University of Vienna demonstrated how ...

The genomics industry is undergoing a profound transformation, moving decisively from a research-focused field to one centered on widespread clinical implementation. This shift sees high-throughput ...

In a groundbreaking study published in BME Frontiers , researchers from the University of California, Los Angeles (UCLA), in ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...

Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...

Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

This study introduces an unprecedented resource of thousands of 3D images representing the diversity of an ecologically dominant group of insects: ants. These data were generated using high-throughput ...